
Why Kenya Must Act Now to Adopt the R21 Malaria Vaccine
Kenya, once a leader in malaria vaccine trials, now lags behind in adopting the R21/Matrix-M vaccine, a more cost-effective and scalable alternative to RTS,S, while neighboring countries forge ahead, writes Gibson Maina, the Country-Specific Lead at …